Market Overview:
The global radix isatidis market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for herbal medicines and the rising awareness about their benefits. Radix isatidis, also known as Chinese gentian, is a perennial herb that has been used in traditional Chinese medicine for centuries. It has various applications such as pharmacy, hospital and other applications. North America dominates the global radix isatidis market followed by Europe and Asia Pacific.
Product Definition:
Radix Isatidis is a herbal medicine that is used to treat a variety of illnesses. It has been shown to be effective in treating respiratory infections, headaches, and other ailments.
Grain:
Grain is a potential form of digital cash that can be used to make secure online transactions. It's an open-source, decentralized, and peer-to-peer digital currency. Its mainnet was launched in July 2016 and has been live since September 2016 with no major bugs found so far. The developers have been working on the proof of stake algorithm to replace the current proof of work algorithm which is expected to be finished by 2018.
Capsule:
Capsule is a device that contains the active ingredient of the drug and it's used to protect drug during travel through different medium. It can be oral, transdermal, topical or injectable. Capsules are widely used in pharmaceutical industry as they offer certain advantages over other packaging options such as unit dose delivery, tamper evidence and high quality control among others.
Application Insights:
The radix isatidis market has been segmented on the basis of application into pharmacy, hospital and others. The pharmacy segment held the largest share in 2017 due to high product usage in compounding Pharmacy. Compounding pharmacists use a wide range of ingredients including herbs, plants and roots, barks, stems and leaves along with synthetic or natural compounds to prepare medicines that are unique to each individual’s condition. These ingredients act as catalysts for different body processes thereby improving overall health outcomes.
Hospitality includes hotels & restaurants as well as healthcare facilities which offer foodservice operations at both institutional and commercial levels ranging from small cafeterias/libraries/student centers to large hospitals & medical schools etc.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing region over the forecast period. The growth can be attributed to rising geriatric population, increasing disposable income and healthcare expenditure, and growing awareness about nutritional products. Moreover, favorable government initiatives for promoting generic drugs in Japan are anticipated to fuel regional market growth during the forecast period.
Europe accounted for a significant share of global revenue in 2017 owing to high demand from countries such as Germany and France. However, stringent regulations by European Medicines Agency (EMA) may hinder industry growth over the next eight years due to lack of product innovation or new product development activities by manufacturers operating within this region.
Growth Factors:
- Increasing awareness about the health benefits of Radix Isatidis is expected to drive its demand in the global market.
- The growing popularity of traditional Chinese medicine is projected to boost the growth of Radix Isatidis market in near future.
- Rising number of research and development activities for new applications of Radix Isatidis is likely to create new opportunities for this market in coming years.
- Growing demand from nutraceuticals and functional food industries is anticipated to fuel the growth of Radix Isatis market over next few years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Radix Isatidis Market Research Report
By Type
Grain, Capsule, Other
By Application
Pharmacy, Hospital, Other
By Companies
Guangzhou Baiyun Mountain Pharmaceutical Group, Huarun 39 pharmaceuticals Limited by Share Ltd, China Beijing Tongrentang (Group) Co., Ltd., Guangzhou Xiangxue pharmaceutical Limited by Share Ltd, Yunnan Baiyao Group Limited by Share Ltd, Revised Pharmaceutical Group Limited by Share Ltd, Jilin Aodong Pharmaceutical Group Corporation, Taiji Group Ltd, Anhui Hua Tuo national drug Limited by Share Ltd, Li Shizhen Medical Group Ltd, Guangzhou Baiyun Mountain Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Radix Isatidis Market Report Segments:
The global Radix Isatidis market is segmented on the basis of:
Types
Grain, Capsule, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmacy, Hospital, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Guangzhou Baiyun Mountain Pharmaceutical Group
- Huarun 39 pharmaceuticals Limited by Share Ltd
- China Beijing Tongrentang (Group) Co., Ltd.
- Guangzhou Xiangxue pharmaceutical Limited by Share Ltd
- Yunnan Baiyao Group Limited by Share Ltd
- Revised Pharmaceutical Group Limited by Share Ltd
- Jilin Aodong Pharmaceutical Group Corporation
- Taiji Group Ltd
- Anhui Hua Tuo national drug Limited by Share Ltd
- Li Shizhen Medical Group Ltd
- Guangzhou Baiyun Mountain Pharmaceutical Group
Highlights of The Radix Isatidis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Grain
- Capsule
- Other
- By Application:
- Pharmacy
- Hospital
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Radix Isatidis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Radix isatidis is a plant species in the family Asteraceae. It is endemic to Ecuador.
Some of the major companies in the radix isatidis market are Guangzhou Baiyun Mountain Pharmaceutical Group, Huarun 39 pharmaceuticals Limited by Share Ltd, China Beijing Tongrentang (Group) Co., Ltd., Guangzhou Xiangxue pharmaceutical Limited by Share Ltd, Yunnan Baiyao Group Limited by Share Ltd, Revised Pharmaceutical Group Limited by Share Ltd, Jilin Aodong Pharmaceutical Group Corporation, Taiji Group Ltd, Anhui Hua Tuo national drug Limited by Share Ltd, Li Shizhen Medical Group Ltd, Guangzhou Baiyun Mountain Pharmaceutical Group.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Radix Isatidis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Radix Isatidis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Radix Isatidis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Radix Isatidis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Radix Isatidis Market Size & Forecast, 2020-2028
4.5.1 Radix Isatidis Market Size and Y-o-Y Growth
4.5.2 Radix Isatidis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Grain
5.2.2 Capsule
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmacy
6.2.2 Hospital
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Radix Isatidis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Radix Isatidis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Grain
9.6.2 Capsule
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmacy
9.10.2 Hospital
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Grain
10.6.2 Capsule
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmacy
10.10.2 Hospital
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Grain
11.6.2 Capsule
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmacy
11.10.2 Hospital
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Grain
12.6.2 Capsule
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmacy
12.10.2 Hospital
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Grain
13.6.2 Capsule
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmacy
13.10.2 Hospital
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Radix Isatidis Market: Competitive Dashboard
14.2 Global Radix Isatidis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Guangzhou Baiyun Mountain Pharmaceutical Group
14.3.2 Huarun 39 pharmaceuticals Limited by Share Ltd
14.3.3 China Beijing Tongrentang (Group) Co., Ltd.
14.3.4 Guangzhou Xiangxue pharmaceutical Limited by Share Ltd
14.3.5 Yunnan Baiyao Group Limited by Share Ltd
14.3.6 Revised Pharmaceutical Group Limited by Share Ltd
14.3.7 Jilin Aodong Pharmaceutical Group Corporation
14.3.8 Taiji Group Ltd
14.3.9 Anhui Hua Tuo national drug Limited by Share Ltd
14.3.10 Li Shizhen Medical Group Ltd
14.3.11 Guangzhou Baiyun Mountain Pharmaceutical Group
